Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRAVE 3
NCT00133250Phase 4Completed
- Sponsor
- Deutsches Herzzentrum München
- Start
- Jun 2003
- Primary completion
- Feb 2008
- Modality
- Antibody Fragments, Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 4 trial of abciximab in acute myocardial infarction (AMI), sponsored by Deutsches Herzzentrum München. Started Jun 2003; status: completed.
02
Drugs
abciximab
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT00133250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00133250.